| Title : Monoacylglycerol lipase reprograms hepatocytes and macrophages to promote liver regeneration - Allaire_2023_JHEP.Rep_5_100794 |
| Author(s) : Allaire M , Al Sayegh R , Mabire M , Hammoutene A , Siebert M , Car C , Cadoux M , Wan J , Habib A , Le Gall M , de la Grange P , Guillou H , Postic C , Paradis V , Lotersztajn S , Gilgenkrantz H |
| Ref : JHEP Rep , 5 :100794 , 2023 |
| Abstract : |
| PubMedSearch : Allaire_2023_JHEP.Rep_5_100794 |
| PubMedID: 37520673 |
| Title : Monoacylglycerol lipase reprograms hepatocytes and macrophages to promote liver regeneration - Allaire_2023_JHEP.Rep_5_100794 |
| Author(s) : Allaire M , Al Sayegh R , Mabire M , Hammoutene A , Siebert M , Car C , Cadoux M , Wan J , Habib A , Le Gall M , de la Grange P , Guillou H , Postic C , Paradis V , Lotersztajn S , Gilgenkrantz H |
| Ref : JHEP Rep , 5 :100794 , 2023 |
| Abstract : |
| PubMedSearch : Allaire_2023_JHEP.Rep_5_100794 |
| PubMedID: 37520673 |
| Title : Monoacylglycerol lipase reprograms hepatocytes and macrophages to promote liver regeneration - Allaire_2023_JHEP.Rep_5_100794 |
| Author(s) : Allaire M , Al Sayegh R , Mabire M , Hammoutene A , Siebert M , Car C , Cadoux M , Wan J , Habib A , Le Gall M , de la Grange P , Guillou H , Postic C , Paradis V , Lotersztajn S , Gilgenkrantz H |
| Ref : JHEP Rep , 5 :100794 , 2023 |
| Abstract : |
| PubMedSearch : Allaire_2023_JHEP.Rep_5_100794 |
| PubMedID: 37520673 |
| Title : First-In-Human Effects of PPT1 Inhibition Using the Oral Treatment with GNS561\/Ezurpimtrostat in Patients with Primary and Secondary Liver Cancers - Harding_2022_Liver.Cancer_11_268 |
| Author(s) : Harding JJ , Awada A , Roth G , Decaens T , Merle P , Kotecki N , Dreyer C , Ansaldi C , Rachid M , Mezouar S , Menut A , Bestion EN , Paradis V , Halfon P , Abou-Alfa GK , Raymond E |
| Ref : Liver Cancer , 11 :268 , 2022 |
| Abstract : |
| PubMedSearch : Harding_2022_Liver.Cancer_11_268 |
| PubMedID: 35949290 |
| Title : First-In-Human Effects of PPT1 Inhibition Using the Oral Treatment with GNS561\/Ezurpimtrostat in Patients with Primary and Secondary Liver Cancers - Harding_2022_Liver.Cancer_11_268 |
| Author(s) : Harding JJ , Awada A , Roth G , Decaens T , Merle P , Kotecki N , Dreyer C , Ansaldi C , Rachid M , Mezouar S , Menut A , Bestion EN , Paradis V , Halfon P , Abou-Alfa GK , Raymond E |
| Ref : Liver Cancer , 11 :268 , 2022 |
| Abstract : |
| PubMedSearch : Harding_2022_Liver.Cancer_11_268 |
| PubMedID: 35949290 |
| Title : First-In-Human Effects of PPT1 Inhibition Using the Oral Treatment with GNS561\/Ezurpimtrostat in Patients with Primary and Secondary Liver Cancers - Harding_2022_Liver.Cancer_11_268 |
| Author(s) : Harding JJ , Awada A , Roth G , Decaens T , Merle P , Kotecki N , Dreyer C , Ansaldi C , Rachid M , Mezouar S , Menut A , Bestion EN , Paradis V , Halfon P , Abou-Alfa GK , Raymond E |
| Ref : Liver Cancer , 11 :268 , 2022 |
| Abstract : |
| PubMedSearch : Harding_2022_Liver.Cancer_11_268 |
| PubMedID: 35949290 |